Drugmaker Takeda's CEO Weber to step down, raises profit forecast - Reuters
  Angioedema Treatment Market Insights and Forecast from 2025 - openPR.com
  Five years after closing the Shire deal, Takeda is ready to harvest from its latest reinvention - Pharma Voice
  Fast-Growing Shire Had Pharmaceutical Rivals in a Takeover Frenzy - WSJ
  Takeda Wins Shareholder Approval for $62 Billion Shire Deal - Bloomberg.com
  Takeover whispers about Shire growing much louder - The Boston Globe
  Shire board recommends £46bn takeover by Takeda - Financial Times
  Takeda to buy Shire for $62B, creating state’s largest drugmaker - The Business Journals